Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × Neoadjuvant Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma 3 Rectal Neoplasms 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma Of Esophagus 3 Pancreatic Neoplasms 2 Osteosarcoma 2 Multiple Myeloma 2 Carcinoma, Intraductal, Noninfiltrating 2 Vomiting 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nausea 1 Microsatellite Instability 1 Malignant mesenchymal tumor 1

Interventions

Cyclophosphamide 31 Dexamethasone 28 Cytarabine 20 fludarabine phosphate 18 Rituximab 18 Lenalidomide 16 Methotrexate 15 Bortezomib 15 fludarabine 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 pembrolizumab 12 Peripheral Blood Stem Cell Transplantation 12 Mycophenolic Acid 12 Etoposide 12 Melphalan 11 Gemcitabine 11 Filgrastim 11 Cyclosporine 11 Paclitaxel 10 pomalidomide 9 Carboplatin 9 Vincristine 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Busulfan 8 Brentuximab Vedotin 8 Bevacizumab 8 carfilzomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡